Advertisement

Injectable Corticosteroids

  • Devang PadaliaEmail author
  • Neal Shah
  • Jaspreet Singh
  • Navdeep Jassal
  • Corey Reeves
  • Randall P. Brewer
Chapter

Abstract

The anti-inflammatory properties of injectable corticosteroids are commonly used to treat a variety of chronic pain conditions. The primary role for the injection of corticosteroids is to reduce inflammation and pain through the localized delivery of the medication to target tissue in efforts to maximize benefit and limit systemic side effects. Spinal injections, such as epidural steroid injections (ESI), facet joint injections, and sacroiliac injections, are frequently utilized interventions to treat spine and radicular pain, while joint, muscle, and tendon sheath injections are commonly used for a variety of musculoskeletal pain conditions. Peripheral nerve blocks, utilized for perioperative anesthesia and analgesia, may include a corticosteroid component for the enhancement of neural blockade and analgesia. The appropriate utilization of injectable corticosteroids takes into consideration the aspects of safety according to site and contents of injection, as well as potential associated systemic consequences. This chapter reviews the unique set of properties of the most commonly utilized injectable corticosteroids and highlights key aspects of their use in epidural and musculoskeletal injections.

Keywords

Injectable corticosteroids Epidural steroid injections Transforaminal Interlaminar Particulate Non-particulate Dexamethasone Methylprednisolone Triamcinolone Joint injection anti-inflammatory 

Recommended Reading

  1. 1.
    Bateman BT, Brenner GJ. An important step forward in the safe use of epidural steroid injections. Anesthesiology. 2015;122:964–6.CrossRefGoogle Scholar
  2. 2.
    Benzon HT, et al. Comparison of the particle sizes of different steroids and the effect of dilution: a review of the relative neurotoxicities of the steroids. Anesthesiology. 2007;106(2):331–8.CrossRefGoogle Scholar
  3. 3.
    Craig DB, Habib GG. Flaccid paraparesis following obstetrical epidural anesthesia: possible role of benzyl alcohol. Anesth Analg. 977(56):219–21.CrossRefGoogle Scholar
  4. 4.
    Denis I, Claveau G, Filiatrault M. Randomized double-blind controlled trial comparing the effectiveness of lumbar transforaminal epidural injections of particulate and nonparticulate corticosteroids for lumbosacral radicular pain. Pain Med. 2015;16:1697–708.CrossRefGoogle Scholar
  5. 5.
    Derby R, Lee SH, Date ES, Lee JH, Lee CH. Size and aggregation of corticosteroids used for epidural injections. Pain Med. 2008;9(2):227–34.CrossRefGoogle Scholar
  6. 6.
    Dreyfuss P, Baker R, Bogduk N. Comparative effectiveness of cervical transforaminal injections with particulate and nonparticulate corticosteroid preparations for cervical radicular pain. Pain Med. 2006;7:237–42.CrossRefGoogle Scholar
  7. 7.
    El-Yahchouchi CE, Geske J, Carter RE. The noninferiority of the nonparticulate steroid dexamethasone vs the particulate steroids betamethasone and triamcinolone in lumbar transforaminal epidural steroid injections. Pain Med. 2013;14:1650–7.CrossRefGoogle Scholar
  8. 8.
    Foster Z, Voss T, Hatch J, Drimodig A. Corticosteroid injections for common musculoskeletal conditions. Am Fam Physician. 2015;92:694–9.PubMedGoogle Scholar
  9. 9.
    Freire V, Bureau NJ. Injectable corticosteroids: take precautions and use caution. Semin Musculoskelet Radiol. 2016;20:401–8.CrossRefGoogle Scholar
  10. 10.
    Jüni P, Hari R, Rutjes AWS, Fischer R, Silletta MG, Reichenbach S, da Costa BR. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. 2015;10:CD005328.  https://doi.org/10.1002/14651858.CD005328.pub3.
  11. 11.
    Kennedy DJ, Plastaras C, Casey E. Comparative effectiveness of lumbar transforaminal epidural steroid injections with particulate versus nonparticulate corticosteroids for lumbar radicular pain due to intervertebral disc herniation: a prospective, randomized, double-blind trial. Pain Med. 2014;15:548–55.CrossRefGoogle Scholar
  12. 12.
    Kim D, Brown J. Efficacy and safety of lumbar epidural dexamethasone versus methylprednisolone in the treatment of lumbar radiculopathy: a comparison of soluble versus particulate steroids. Clin J Pain. 2011;27:518–22.CrossRefGoogle Scholar
  13. 13.
    Lee JW, Park KW, Chung SK. Cervical transforaminal epidural steroid injection for the management of cervical radiculopathy: a comparative study of particulate verse non-particulate steroids. Skelet Radiol. 2009;38:1077–82.CrossRefGoogle Scholar
  14. 14.
    MacMahon PJ, Eustace SJ, Kavanagh EC. Injectable corticosteroid and local anesthetic preparations: a review for radiologists. Radiology. 2009;252(3):647–61.CrossRefGoogle Scholar
  15. 15.
    MacMahon PJ, Huang AJ, Palmer WE. Spine injectables: what is the safest cocktail? AJR. 2016;207:526–33.CrossRefGoogle Scholar
  16. 16.
    Manchikanti L. Role of neuraxial steroids in interventional pain management. Pain Physician. 2002;5:182–99.PubMedGoogle Scholar
  17. 17.
    Mehta P, Syrop I, Singh JR, Kirschner J. Systematic review of the efficacy of particulate versus nonparticulate corticosteroids in epidural injections. PMRJ. 2017;9(5):502–12.  https://doi.org/10.1016/j.pmrj.2016.11.008.CrossRefGoogle Scholar
  18. 18.
    Park CH, Lee SH, Kim B. Comparison of the effectiveness of lumbar transforaminal epidural injection with particulate and nonparticulate corticosteroids in lumbar radiating pain. Pain Med. 2010;11:1654–8.CrossRefGoogle Scholar
  19. 19.
    Pinto RZ, Maher CG, Ferreira ML, et al. Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-analysis. Ann Intern Med. 2012;157(12):865–77.CrossRefGoogle Scholar
  20. 20.
    Rincon I, Battafarano D, Restrepo J, Erikson J, Escalante A. Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol. 2014;66:264–72.CrossRefGoogle Scholar
  21. 21.
    Shakir A, Ma V, Mehta B. Comparison of pain score reduction using triamcinolone vs. dexamethasone in cervical transforaminal epidural steroid injections. Am J Phys Med Rehabil. 2013;92:768–75.CrossRefGoogle Scholar
  22. 22.
    Shamliyan TA, Bart Staal J, Goldmann D, Sands-Lincoln M. Epidural steroid injections for radicular lumbosacral pain: a systematic review. Phys Med Rehabil Clin N Am. 2014;25:471–89.CrossRefGoogle Scholar
  23. 23.
    U.S. Food and Drug Administration (FDA). FDA drug safety communication: FDA requires label changes to warn of rare but serious neurologic problems after epidural corticosteroid injections for pain. FDA Website. www.fda.gov/Drugs/DrugSafety/ucm394280.htm. Published April 23, 2014. Accessed 13 May 2016.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Devang Padalia
    • 1
    Email author
  • Neal Shah
    • 1
  • Jaspreet Singh
    • 2
  • Navdeep Jassal
    • 2
  • Corey Reeves
    • 3
  • Randall P. Brewer
    • 4
  1. 1.Interventional Pain DepartmentMoffitt Cancer Center, University of South FloridaTampaUSA
  2. 2.Department of NeurologyUniversity of South FloridaTampaUSA
  3. 3.Department of Physical Medicine and RehabilitationUniversity of South FloridaTampaUSA
  4. 4.Department of Neurology and AnesthesiologyLouisiana State UniversityShreveportUSA

Personalised recommendations